SG/PUT/ELI LILLY & CO/700/0.01/20.12.24 Stock

DE000SU6VLX5

Market Closed - Boerse Frankfurt Warrants 03:47:10 2024-07-08 pm EDT
0.09 ^EUR	-10.00%

Current month	-10.00%
1 month	-47.06%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart ELI LILLY AND COMPANY

Chart SG/PUT/ELI LILLY & CO/700/0.01/20.12.24

Latest news about ELI LILLY AND COMPANY

Weight loss drug Zepbound outperforms Ozempic in new published study	06:32pm	AQ
Health Care Flat Amid Deal Activity -- Health Care Roundup	Jul. 08	DJ
S&P 500, Nasdaq Extend Record Closing Runs	Jul. 08	MT
S&P 500, Nasdaq Extend Record High Closing Runs	Jul. 08	MT

More news

Quotes 5-day view

Date	Price	Change
24-07-08	0.09	-10.00%
24-07-05	0.1	-16.67%
24-07-04	0.12	0.00%
24-07-03	0.12	+9.09%
24-07-02	0.11	+13.40%

Real-time Boerse Frankfurt Warrants

Last update July 08, 2024 at 03:47 pm EDT

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	PUT
Underlying	ELI LILLY AND COMPANY
Issuer	Société Générale
WKN	SU6VLX
ISIN	DE000SU6VLX5
Date issued	2024-01-10
Strike	700 $
Maturity	2024-12-20 (165 Days)
Parity	100 : 1
Emission price	1.01 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	1.05 €
Lowest since issue	0.089 €
Spread	0.01 €
Spread %	10.00%

Company Profile

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunology diseases (11.1%); - neurology (8.4%): primarily drugs used in treating depression and schizophrenia; - other (3.3%). Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).

Sector

More about the company